Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Depigmented hair regrowth after alopecia areata can be permanent.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Permanent hair dye may cause total hair loss.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

More research is needed on alopecia areata treatments and its psychological effects.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Hominis Placenta Pharmacopunture helped regrow hair in a patient with stress-induced hair loss.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Diphencyprone helped most patients with alopecia areata regrow some hair.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.